Currently, the global sleep disorder market is segmented into five major regions – North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Growth is anticipated in North America owing to rising awareness about sleep disorders and increasing healthcare expenditures in the region. Furthermore, the presence of a well-established healthcare sector is likely to spur industry development. In the coming years, the industry will experience steady growth thanks to the emergence of new products and technological advancements.
The rise in geriatric population is a major factor supporting the market’s progression. By 2050, the world’s population will reach 2 billion, and an estimated 13% to 32% of these people will be 65 years or older. Thus, the increasing prevalence of sleep disorders will drive demand for sleep disorder therapeutic devices and medications. During the recent pandemic, the market witnessed an increase in sleep disorders. However, lockdowns, disruptions in the supply chain, and postponing of non-emergency cases hampering the market’s growth. However, the impact of COVID-19 is expected to continue to increase over the next few years, with the market boosting further.
A Sleep Disorder market report provides an in-depth analysis of the industry’s competitive landscape, key drivers, and growth potential. The report also identifies trends and other factors that will affect market growth and profitability. It also provides a forecast of the market size over the next five years, from 2020 to 2025. The global GDP was USD 84,740.3 billion in 2018, up 5.73% over the previous year. The increase in GDP is likely to drive market growth in the future.
As an industry, the global sleep disorder market is highly fragmented. A few players produce generic medications, while only a few companies market branded products. Moreover, price sensitivity is a major concern in several regions. Therefore, companies are focusing on developing novel molecules and new chemical entities to compete in this competitive market. Major players in the market include Takeda Pharmaceuticals USA Inc., Pfizer, Mylan NV, and Teva Pharmaceuticals USA Inc.
Technological advancements are expected to drive the global sleep disorder market growth over the coming years. In February 2021, the US Food and Drug Administration will approve the sale of eXciteOSA, a prescription-only device that administers electrical muscle stimulation. The mouthpiece of the device allows optimal ventilation, and the device can be used while awake. Therefore, this is expected to be a game changer in the global sleep disorder market.
The global sleep disorder market is largely driven by increasing awareness of the prevalence of these disorders. Not only do these disorders cause sleep deprivation, they can also cause serious health problems, including allergies, respiratory issues, and chronic pain. Furthermore, they can cause significant levels of stress and anxiety. As a result, the prevalence of sleep disorders is predicted to rise at a steady pace, and the demand for products and services that address the problem are rising.
The global sleep aids market is projected to expand at a CAGR of 7.8% during the forecast period (2018-2027). Increased healthcare expenditure and increasing prevalence of sleep disorders are the primary driving forces for the growth of this industry in this region. Additionally, the growing geriatric population will boost regional demand for sleep aids. Other key players in the sleep aids market include GlaxoSmithKline, ResMed, and Royal Philips NV.
Several major manufacturers of sleep aids are competing in the global sleep aids market. Some of these companies include BioSerenity, DeVilbiss Healthcare LLC, Compumedics Limited, D & DJ Burton Holdings Pty Ltd., and Cadwell Industries, Inc. Other leading manufacturers in the market include Sanofi, Pfizer, and Natus Medical Manufactures. In addition, Sandland Sleep, an Australian company, is launching generic versions of its marketed Ramelteon tablets in July 2021.
The prevalence of sleep disorders is the primary driving force behind the growth of the global sleep aids market. A lack of adequate sleep affects human health and negatively impacts their quality of life. People suffering from sleep disorders usually struggle to fall asleep, wake up exhausted, and perform poorly in their professional or personal life. Consequently, they can affect their immune system, mood, and quality of life. This has spurred the development of portable sleep apnea devices, which are increasingly popular amongst both adults and children.
The COVID-19 pandemic has negatively affected the sleep aids market in a number of ways. The disease is transmitted from humans to humans and causes respiratory problems. As a result, the global trade in sleeping aids has been severely affected. Additionally, the outbreak of COVID-19 has resulted in the closure of several manufacturing facilities, reducing the demand for sleep aids. Moreover, the limited supply in ports has impacted the production of these products.
In 2020, North America accounted for a large portion of the global sleep aids market. This region is projected to maintain its dominance during the forecast period. This region has developed healthcare infrastructures and trained medical professionals. In addition, the presence of key players in the region is another driving factor. Meanwhile, Asia-Pacific is expected to experience the fastest growth in the market. While the North American market dominated the global sleep aids market in 2020, the Asia-Pacific region is expected to have the highest CAGR during the forecast period.
The Global Sleep Aids market report provides in-depth information about the market, including revenue, volume, size, and value. The report also examines the market’s competitive landscape, key trends, and regional breakdowns. The report also includes key statistics about leading players in the market. It is also essential for evaluating the current situation of the industry. You’ll find out how to best utilize the available data and determine how to gain competitive advantage in the market.
Several factors have contributed to the growth of the global sleep aids market in recent years. Increasing disposable income and the aging population are major drivers of this market. Additionally, the growing geriatric population and obesity are increasing the prevalence of sleep disorders. Despite these factors, a large portion of these products suffer from side effects. As such, the market is projected to grow at a 4.5% CAGR during the forecast period.
The sleep apnea devices market is driven by factors such as the increasing prevalence of the disorder, growing geriatric population, and the need for home testing and monitoring tools. Rising awareness of sleep apnea and the rise in prevalence of obesity and hypertension are the other factors boosting the growth of the market. However, lack of patient compliance is likely to be the biggest challenge in the years to come.
In developing economies, the lack of insurance coverage for these devices will hamper market growth. As a result, international market front-runners have entered into agreements with local companies to provide their products in the region. The lack of awareness among the general public is another key factor hampering market growth in the region. To overcome these challenges, the industry should invest in marketing and advertising activities to improve patient acceptance of sleep apnea devices. Advertising and awareness-raising campaigns will also help convince insurance companies to cover the cost of OSA treatments.
The COVID-19 pandemic is also expected to boost the sleep apnea devices market. The virus is the largest cause of death from COVID-19. A study by Philips found that a significant proportion of respondents experienced increased sleep challenges after the COVID-19 pandemic. This increase in apnea treatment has led to an increased use of sleep apnea devices.
The market for sleep apnea devices is divided into two segments: therapeutic and diagnostic. The therapeutic devices segment comprises positive airway pressure, nasal devices, and continuous positive airway pressure systems. Diagnostic products include respiratory polygraphs and oximeters. The therapeutic devices segment is expected to grow at a high rate during the forecast period. The market for sleep apnea devices is segmented by end-user, geography, and type.
Throughout the study, the global sleep apnea devices market is segmented and sub-segmented by region. This region accounts for around 40% of the global market. Consequently, North America is expected to lead the world with the highest shares. Growth is driven by increasing investments in innovative technologies, such as apnea devices. The report highlights trends and drivers that will influence the industry, and the overall competitive landscape.
Increasing prevalence of diseases and sedentary lifestyles are driving demand for sleep apnea devices. The U.S. is home to over 70 million adults with obesity, and 99 million people are overweight. Moreover, an increasing awareness of sleep disorders is leveraging the market’s growth. And, a rapidly aging population is another factor driving the market growth of sleep apnea devices.
Several major players in the sleep apnea devices market have launched novel products for use in home care settings. For example, Itamar Medical recently announced the approval of its WatchPAT One, an affordable one-use home sleep apnea test that delivers optimum accuracy and reliability to patients. This device is expected to be a game-changer in the sleep apnea devices market.
To address this growing need for a solution, the sleep apnea implants market has become an important area of research. Companies are increasingly focusing on research and development, establishing strategic partnerships with pharmaceutical companies, and achieving regulatory approvals and product launches. In March 2021, Inspire Medical Systems, Inc. received FDA approval for its improved surgical implant procedure. This procedure eliminated one incision and revised the placement of the pressure-sensing lead to reduce the length of the procedure by 20 percent. However, this list is not exhaustive; the complete competitive intelligence is available in the report.
With the growing awareness about sleep disorders and the growing number of people suffering from the condition, the sleep apnea implants market is set to grow rapidly in the coming years. According to the Federal Statistical Office, Germany is the most lucrative market for the device, thanks to the high prevalence of sleep disorders and the government’s initiatives to promote good health. Meanwhile, in China, favorable reimbursement and regulatory scenarios will encourage the market growth.
The report provides accurate market data based on product, indication, and end-user. It also includes pricing analysis and competitive analysis of key players. Furthermore, it offers detailed insights into the competitive landscape of the sleep apnea implants market, and outlines the key factors influencing it. Additionally, the report covers geographic analysis and highlights trends in the industry. The report also covers forecasts for the market.
Inspire Medical Systems, Inc. is the leading player in the sleep apnea implants market. Other major players include LivaNova PLC, Respicardia Inc., and Siesta Medical Inc. The report covers emerging markets as well as established economies. The research report includes data from 2010 to 2020, as well as 147 tables and figures. It also provides an overview of the competitive landscape for the sleep apnea implants market globally.
The report also provides insights into the competitive landscape, drivers, and restraints for the Sleep Apnea Implants Market. It also includes data from government bodies and reveals regional proliferation of the market. This report helps companies formulate growth strategies that can help them maintain their positions in this highly competitive industry. The report also includes profiles of prominent players in the market. The report provides an accurate picture of the global market for sleep apnea implants.
The report also offers detailed market analysis for each country. The report considers factors such as installed base and healthcare expenditure on capital equipment. Lifeline curves help to analyze the impact of technological innovations on the market. The report also examines the impact of various regulatory scenarios on the market. With this data, the sleep apnea implants market is expected to grow at a substantial rate in the coming years.
The COVID-19 pandemic has disrupted medical practices globally, causing a delay in the implementation of sleep apnea therapy and screening patients for treatment eligibility. Post-pandemic, the sleep apnea implants market will see steady growth thanks to rising attention to sleep disorders and increased investments in research and development. The OSA segment is expected to dominate the sleep apnea implants market, while the hypoglossal neurostimulation device will see a significant increase in demand.
The sleep eye mask market is a rapidly growing industry, driven by the increasing number of consumers who suffer from various sleeping disorders. The changing climate patterns and hectic lifestyle have resulted in a growing number of people suffering from various sleep disorders. Sleep masks can assist these individuals, especially in developing countries and regions. These products are a natural remedy that promotes healthy sleep. Moreover, the growing demand for therapeutic masks is expected to further drive the growth of the sleep eye mask market.
While regular sleep masks held the dominant position in the global market in 2018, the growth of contoured sleep masks was significantly higher during the same period. These masks offer a more comfortable sleeping environment as they do not place pressure on the eyelids. As these masks do not contain lenses, they are more comfortable to wear. Moreover, they are less bulky and easier to carry around. Among the regions, North America is expected to grow at the highest CAGR during the forecast period, primarily owing to the increased prevalence of sleep disorders.
The growth of the sleep mask market is expected to remain high in the coming years. This industry is driven by a number of factors, including the expanding travel industry. The number of flights to and from major destinations and the increasing aging population, which makes it difficult to sleep at night, have significantly increased the use of sleep masks. In addition, the rise in prevalence of sleep disorders and the growing number of alternative treatments has led to an increased demand for sleep masks.
The COVID-19 pandemic is affecting the supply chain and reducing raw material availability. In addition to these challenges, the global sleep mask market is experiencing a period of slowdown due to shortage of resources and staff. However, the rising awareness of the importance of sleep plays an important role in the growth of this industry. As a result, a significant recovery is expected in the near future. In the meantime, a partial lifting of lockdowns is expected to boost the overall market.
North America has the largest share of the sleep mask market, accounting for 60 percent of the overall market in 2018. As a result, the region is expected to experience a high rate of new product launches, including the Sisley Paris Velvet Sleeping Mask, which provides long-lasting hydration and softness. Other companies in the market are adopting omnichannel retail strategies to reach a wider demographic. Olay launched a new sleep mask in July 2019, aimed at providing nourishing sleep.
A recent study conducted by MarketResearch.com suggests that aromatherapy masks are increasing in popularity in North America, especially among people suffering from insomnia. These masks contain plant extracts, which aid in achieving rapid sleep. They also help relieve stress and alleviate pain from sinuses and migraines. As a result of this rise in popularity, North America led the global sleep mask market in 2018, accounting for nearly 60% of the total revenue.